Literature DB >> 28153841

Cholic Acid Feeding Leads to Increased CYP2D6 Expression in CYP2D6-Humanized Mice.

Xian Pan1, Rebecca Kent1, Kyoung-Jae Won1, Hyunyoung Jeong2.   

Abstract

Cytochrome P450 2D6 (CYP2D6) is a major drug-metabolizing enzyme, but the factors governing transcriptional regulation of its expression remain poorly understood. Based on previous reports of small heterodimer partner (SHP) playing an important role as a transcriptional repressor of CYP2D6 expression, here we investigated how a known upstream regulator of SHP expression, namely cholestasis triggered by cholic acid (CA) feeding in mice, can lead to altered CYP2D6 expression. To this end, CYP2D6-humanized (Tg-CYP2D6) mice were fed with a CA-supplemented or control diet for 14 days, and hepatic expression of multiple genes was examined. Unexpectedly, CA feeding led to insignificant changes in SHP mRNA but also to significant (2.8-fold) decreases in SHP protein levels. In silico analysis of the SHP gene regulatory region revealed a putative binding site for a microRNA, miR-142-3p. Results from luciferase reporter assays suggest that miR-142-3p targets the SHP gene. Hepatic expression of miR-142-3p was significantly increased in CA-fed mice (∼5-fold), suggesting a potential role of miR-142-3p in the regulation of SHP expression in cholestasis. The decreased SHP protein levels were accompanied by increased expression and activity of CYP2D6 in the liver of CA-fed mice. These results suggest potential roles of differential hepatic levels of bile acids in the transcriptional regulation of CYP2D6 expression.
Copyright © 2017 by The American Society for Pharmacology and Experimental Therapeutics.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28153841      PMCID: PMC5363697          DOI: 10.1124/dmd.116.074013

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  37 in total

1.  Comparison between cytochrome P450 (CYP) content and relative activity approaches to scaling from cDNA-expressed CYPs to human liver microsomes: ratios of accessory proteins as sources of discrepancies between the approaches.

Authors:  K Venkatakrishnan; L L von Moltke; M H Court; J S Harmatz; C L Crespi; D J Greenblatt
Journal:  Drug Metab Dispos       Date:  2000-12       Impact factor: 3.922

Review 2.  The interaction between bacteria and bile.

Authors:  Máire Begley; Cormac G M Gahan; Colin Hill
Journal:  FEMS Microbiol Rev       Date:  2005-09       Impact factor: 16.408

3.  Sulphated and unsulphated bile acids in serum, bile, and urine of patients with cholestasis.

Authors:  G P van Berge Henegouwen; K H Brandt; H Eyssen; G Parmentier
Journal:  Gut       Date:  1976-11       Impact factor: 23.059

4.  Estrogen receptor alpha mediates 17alpha-ethynylestradiol causing hepatotoxicity.

Authors:  Yukio Yamamoto; Rick Moore; Holly A Hess; Grace L Guo; Frank J Gonzalez; Kenneth S Korach; Robert R Maronpot; Masahiko Negishi
Journal:  J Biol Chem       Date:  2006-04-10       Impact factor: 5.157

5.  Repression of the nuclear receptor small heterodimer partner by steatotic drugs and in advanced nonalcoholic fatty liver disease.

Authors:  Marta Benet; Carla Guzmán; Sandra Pisonero-Vaquero; M Victoria García-Mediavilla; Sonia Sánchez-Campos; M Luz Martínez-Chantar; M Teresa Donato; José Vicente Castell; Ramiro Jover
Journal:  Mol Pharmacol       Date:  2015-01-09       Impact factor: 4.436

6.  Regeneration of serotonin from 5-methoxytryptamine by polymorphic human CYP2D6.

Authors:  Ai-Ming Yu; Jeffrey R Idle; Linda G Byrd; Kristopher W Krausz; Adrian Küpfer; Frank J Gonzalez
Journal:  Pharmacogenetics       Date:  2003-03

7.  Resistance of SHP-null mice to bile acid-induced liver damage.

Authors:  Li Wang; Yunqing Han; Chang-Soo Kim; Yoon-Kwang Lee; David D Moore
Journal:  J Biol Chem       Date:  2003-08-21       Impact factor: 5.157

8.  Cytochrome P450 expression and regulation in CYP3A4/CYP2D6 double transgenic humanized mice.

Authors:  Melanie A Felmlee; Hoi-Kei Lon; Frank J Gonzalez; Ai-Ming Yu
Journal:  Drug Metab Dispos       Date:  2007-11-29       Impact factor: 3.922

9.  Functional specificities of Brm and Brg-1 Swi/Snf ATPases in the feedback regulation of hepatic bile acid biosynthesis.

Authors:  Ji Miao; Sungsoon Fang; Jiyoung Lee; Clay Comstock; Karen E Knudsen; Jongsook Kim Kemper
Journal:  Mol Cell Biol       Date:  2009-10-05       Impact factor: 4.272

10.  Intestine-selective farnesoid X receptor inhibition improves obesity-related metabolic dysfunction.

Authors:  Changtao Jiang; Cen Xie; Ying Lv; Jing Li; Kristopher W Krausz; Jingmin Shi; Chad N Brocker; Dhimant Desai; Shantu G Amin; William H Bisson; Yulan Liu; Oksana Gavrilova; Andrew D Patterson; Frank J Gonzalez
Journal:  Nat Commun       Date:  2015-12-15       Impact factor: 14.919

View more
  4 in total

Review 1.  P450-Humanized and Human Liver Chimeric Mouse Models for Studying Xenobiotic Metabolism and Toxicity.

Authors:  Karl-Dimiter Bissig; Weiguo Han; Mercedes Barzi; Nataliia Kovalchuk; Liang Ding; Xiaoyu Fan; Francis P Pankowicz; Qing-Yu Zhang; Xinxin Ding
Journal:  Drug Metab Dispos       Date:  2018-08-09       Impact factor: 3.922

2.  Regulation of cytochrome P450 expression by microRNAs and long noncoding RNAs: Epigenetic mechanisms in environmental toxicology and carcinogenesis.

Authors:  Dongying Li; William H Tolleson; Dianke Yu; Si Chen; Lei Guo; Wenming Xiao; Weida Tong; Baitang Ning
Journal:  J Environ Sci Health C Environ Carcinog Ecotoxicol Rev       Date:  2019-07-15       Impact factor: 3.781

Review 3.  Non-coding RNA crosstalk with nuclear receptors in liver disease.

Authors:  Jianguo Wu; Laura E Nagy; Suthat Liangpunsakul; Li Wang
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2021-01-24       Impact factor: 5.187

Review 4.  The long and the small collide: LncRNAs and small heterodimer partner (SHP) in liver disease.

Authors:  Jianguo Wu; Laura E Nagy; Li Wang
Journal:  Mol Cell Endocrinol       Date:  2021-03-26       Impact factor: 4.369

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.